Earnings Call · Q3 FY2024·2024-10-29

Q3 24EPS +92.31%·Rev n/aQ2 24EPS +100.00%*·Rev n/aQ1 24EPS +48.72%·Rev n/aQ4 23EPS -13.89%·Rev n/a⚠ consensus missing

10x Genomics, Inc. TXG

Cassie Corneau — Investor Relations

Serge Saxonov — Co-founder and CEO

Adam Taich — Chief Financial Officer

−24.7%1d on move date−24.5% vs SPY3d−21.8%5d−24.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TXG calls or request research access.

More TXG calls Browse calls Request research access